GeneDx Holdings Corp. (WGS)
Healthcare
Diagnostics & Research
67.90 $
+4.2%
vs. previous close
Closing price · As of: 3. Aug 2026
GeneDx Holdings Corp. (WGS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -32 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -54 | -41 | -30 | -16 | -4.5 | -4.4 | -3.2 | 10 | 10 | 16 | -3.1 | -32 | -9.3 | |
| 10 | 8.7 | 6.7 | 5.2 | 5.2 | 16 | -5.6 | 5.7 | 6.2 | 6.5 | 6.9 | 6.8 | 26 | |
| 0.1 | 0.4 | -0.9 | -0.5 | 3.1 | 3.6 | 2.8 | 4.0 | 7.8 | 11 | 9.8 | 9.0 | 37 | |
| -4.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -9.0 | -14 | -8.4 | -7.7 | -3.5 | -5.8 | -7.8 | 3.4 | -16 | -2.9 | 0.3 | -23 | -42 | |
| 2.8 | 0.1 | 2.4 | 0.4 | 1.4 | 0.6 | 3.1 | 6.1 | 2.4 | 6.2 | 4.3 | 6.5 | 19 | |
| -11 | -27 | -4.9 | 0.8 | -23 | -7.8 | -0.5 | -9.4 | -36 | -4.7 | -11 | -17 | -69 | |
| 7.6 | – | – | – | – | – | – | – | 1.3 | – | – | – | – | |
| -0.2 | – | – | – | – | -0.7 | -1.5 | -0.9 | -0.9 | -1.2 | -0.7 | -59 | -62 | |
| 7.4 | -0.9 | 47 | -0.4 | -0.4 | 14 | 31 | 14 | 0.3 | 11 | 23 | 39 | 73 | |
| -57 | -69 | 12 | -16 | -28 | 1.8 | 27 | 14 | -26 | 22 | 9.0 | -11 | -5.8 | |
| -56 | -41 | -32 | -17 | -5.9 | -5.0 | -6.2 | 4.1 | 8.1 | 9.6 | -7.4 | -39 | -29 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.